Nutex Health, Inc. (NUTX) vs Syndax Pharmaceuticals, Inc. (SNDX)

A side-by-side comparison of Nutex Health, Inc. and Syndax Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NUTX vs SNDX

growth of $100 · dividends reinvested · last 10y
NUTX -96.6% (-28.6%/yr)SNDX +17.3% (+1.6%/yr)SNDX compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020182020202220242026$3$117
NUTX SNDX

NUTX vs SNDX: by the numbers

  • •SNDX is the larger company ($1.54B vs $1.50B market cap).
  • •NUTX is profitable (21.25% net margin) while SNDX runs a net loss (-87.60%).
  • •SNDX grew revenue faster over the past five years (178.06% vs 37.66% CAGR).

Metrics side by side

Valuation

MetricNUTXSNDX
P/E ratio8.64N/A
Forward P/E7.86N/A
P/S ratio1.776.11
P/B ratio3.81101.94
EV / EBITDA4.27N/A
FCF yield18.24%N/A

Profitability

MetricNUTXSNDX
Gross margin51.26%97.47%
Operating margin31.49%-158.45%
Net margin21.25%-87.60%
ROE45.63%-1462.12%
ROIC33.76%-32.15%

Growth (annualized)

MetricNUTXSNDX
Revenue CAGR (5Y)37.66%178.06%
EPS CAGR (5Y)-14.73%N/A
Total return CAGR (5Y)-18.99%-0.01%

Frequently asked

Which has grown faster, NUTX or SNDX?
Over the past five years, SNDX grew revenue faster — NUTX at a 37.66% CAGR versus SNDX at 178.06%.
Is NUTX or SNDX more profitable?
NUTX runs the higher net margin — NUTX at 21.25% versus SNDX at -87.60%.
How have NUTX and SNDX total returns compared?
Over the past 10 years, NUTX delivered -27.99% and SNDX delivered 1.04% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.